Skip to content

A study of the effectiveness of using pulse-indicated continuous cardiac output monitoring techniques and mechanical energy monitoring to optimise the power of mechanical ventilation in patients with permeable pulmonary oedema to reduce lung injury

A study of the effectiveness of using pulse-indicated continuous cardiac output monitoring techniques and mechanical energy monitoring to optimise the power of mechanical ventilation in patients with permeable pulmonary oedema to reduce lung injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084060
Enrollment
Unknown
Registered
2024-05-09
Start date
2024-05-09
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

permeability pulmonary edema

Interventions

observation:The patient was ventilated in prone position during mechanical ventilation
Control:No intervention

Sponsors

The First Affiliated Hospital of Xiamen University, ICU
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged =18 years old, male or female; (2) Diagnosis of permeability pulmonary edema with the following characteristics: hypoxemia (PaO2/FiO2<300 mmHg), reduced lung compliance (<50 mL/cmH2O), chest X-ray or CT showing diffuse lung sexual infiltration shadow; (3) Receive mechanical ventilation treatment, and the ventilation mode is volume control or pressure control; (4) Use the PiCCO system to monitor hemodynamic parameters within 2 hours before enrollment; (5) Sign the informed consent form, or have it signed by its legal representative.

Exclusion criteria

Exclusion criteria: (1) There is cardiogenic pulmonary edema or other types of pulmonary edema; (2) There are heart diseases such as valvular heart disease, cardiomyopathy, pericarditis, cardiac tamponade, and atrial fibrillation; (3) There are pulmonary vascular diseases such as pulmonary embolism, pulmonary hypertension, pulmonary arteriovenous fistula, and post-pneumonectomy; (4) There are large vascular diseases such as aortic aneurysm, aortic dissection, aortic stenosis; (5) There are systemic diseases such as severe liver insufficiency, renal insufficiency, and coagulation dysfunction; (6) There are life-threatening conditions such as severe septic shock, multiple organ failure, intracranial hypertension; (7) There are contraindications to the PiCCO system, such as aneurysm, arteriosclerosis, arterial stenosis, arterial embolism, arteritis, arterial puncture site infection, etc.; (8) Refusing to participate in this study or unable to comply with the requirements of the research protocol.

Design outcomes

Primary

MeasureTime frame
Power of respiratory machinery ;Extravascular lung water volume;

Secondary

MeasureTime frame
PaO2;PETCO2;HR;NLRP3;Duration of mechanical ventilation;

Countries

China

Contacts

Public ContactXu Hao

The First Affiliated Hospital of Xiamen University ICU

xuhao007@asiandoctor.net+86 181 8485 0901

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026